DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Fispemifene is an investigational drug.
There have been 4 clinical trials for Fispemifene. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.
The most common disease conditions in clinical trials are Hypogonadism, Erectile Dysfunction, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are QuatRx Pharmaceuticals Company, Hormos Medical, and NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).
Recent Clinical Trials for Fispemifene
|Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men||NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)||Phase 2|
|Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy||QuatRx Pharmaceuticals Company||Phase 2|
|Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors||Hormos Medical||Phase 2|